⚖

Compare Funds

See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.

MF
—ICICI Prudential Business Cycle Fund - Growth - Direct PlanDirect · Growth
₹24.68 as on 29 Oct 2026
VS
HD
HDFC MFHDFC Pharma and Healthcare Fund - Growth - Direct PlanDirect · Growth
₹21.95 as on 30 Oct 2026
▤Key Metrics Comparison
MetricMFICICI Prudential Business Cycle Fund - Growth - Direct PlanHDHDFC Pharma and Healthcare Fund - Growth - Direct Plan
Snapshot
AMC—HDFC MF
CategoryEquity - Thematic Fund - OtherEquity - Sectoral Fund - Pharma & Health Care
NAV₹24.68 (29 Oct 2026)₹21.95 (30 Oct 2026)
Rating★★★★★★★★
BenchmarkNIFTY 500 - TRIBSE Health Care - TRI
Fund ManagerManish BanthiaNikhil Mathur
Inception18 Jan 202104 Oct 2023
Returns
1Y-9.46%22.64%
3Y14.37%30.41%
5Y13.57%—
Since Inception16.91%29.15%
Risk
13.0214.07
0.890.59
0.581.59
4.1021.67
1.063.48
-13.01%-9.23%
Costs
Expense Ratio1.01%1.03%
Exit Load1% on or before 1M, Nil after 1M1% on or before 30D, Nil after 30D
Min SIP₹100₹100
Min Lumpsum₹500₹100
Lock-inNoneNone

Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.

◐Portfolio Overlap
ICICI Prudent…100%
HDFC MF100%
0.0%

Only 0.0% of holdings by weight are common between ICICI Prudential Business Cycle Fund - Growth - Direct Plan and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.

Category context: Equity vs Equity. Open the full Screener →